Table 1 Eligible Population and Effectiveness Assumptions for Minimum and Maximum Scenarios

Breast

1996

Women; age 50–69 y

0.029 [22]

1996

Women, age 40 + y

0.044 [22]

Colorectal

1996

Age 50–75 y

Flex sig + FIT^a: 0.009 [23]

2002

Age 45–75 y

Colonoscopy: 0.022 [23]

Cervical

1996

Women; age 21–65 y

PAP^b:

0.089 [24]

1996

Women; age 21–65 y

21–30 PAP; 30–65 cotesting^c: 0.096 [24]

Lung

2014

Current smoker or former smoker; age 50–80 y

0.0316 [25]

Limited benefit evidence, same as minimum scenario